0001127602-14-010717.txt : 20140307 0001127602-14-010717.hdr.sgml : 20140307 20140307161700 ACCESSION NUMBER: 0001127602-14-010717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140306 FILED AS OF DATE: 20140307 DATE AS OF CHANGE: 20140307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE KENNETH B JR CENTRAL INDEX KEY: 0001208570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 14677448 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-03-06 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001208570 LEE KENNETH B JR 4505 EMPEROR BLVD., SUITE 200 DURHAM NC 27703 1 Common Stock 2014-03-06 4 M 0 22917 3.80 A 22917 D Common Stock 2014-03-06 4 S 0 12665 12.69 D 10252 D Non-Qualified Stock Option 3.80 2014-03-06 4 M 0 22917 0 D 2011-06-30 2021-06-27 Common Stock 22917 0 D Shares of Common Stock sold to satisfy payment of exercise price, taxes, and related broker fees and commissions for stock option exercise. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.60 to $12.75. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Alane P. Barnes, by power of attorney 2014-03-07